Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 46 entries
Sorted by: Best Match Show Resources per page
Effects of subchronic malathion exposure on the pharmacokinetic disposition of pefloxacin.

Environmental toxicology and pharmacology

Suresh Babu N, Malik JK, Rao GS, Aggarwal M, Ranganathan V.
PMID: 21783705
Environ Toxicol Pharmacol. 2006 Sep;22(2):167-71. doi: 10.1016/j.etap.2006.03.001. Epub 2006 Mar 16.

Malathion is one of the most extensively used organophosphorus pesticides applied in agriculture, mosquito eradication and in the control of animal ectoparasites and human body lice. The widespread use of malathion has raised concern over its potential to cause...

Cite
Suresh Babu N, Malik JK, Rao GS, et al. Effects of subchronic malathion exposure on the pharmacokinetic disposition of pefloxacin. Environ Toxicol Pharmacol. 2006;22(2):167-71doi: 10.1016/j.etap.2006.03.001.
Suresh Babu, N., Malik, J. K., Rao, G. S., Aggarwal, M., & Ranganathan, V. (2006). Effects of subchronic malathion exposure on the pharmacokinetic disposition of pefloxacin. Environmental toxicology and pharmacology, 22(2), 167-71. https://doi.org/10.1016/j.etap.2006.03.001
Suresh Babu, N, et al. "Effects of subchronic malathion exposure on the pharmacokinetic disposition of pefloxacin." Environmental toxicology and pharmacology vol. 22,2 (2006): 167-71. doi: https://doi.org/10.1016/j.etap.2006.03.001
Suresh Babu N, Malik JK, Rao GS, Aggarwal M, Ranganathan V. Effects of subchronic malathion exposure on the pharmacokinetic disposition of pefloxacin. Environ Toxicol Pharmacol. 2006 Sep;22(2):167-71. doi: 10.1016/j.etap.2006.03.001. Epub 2006 Mar 16. PMID: 21783705.
Copy Download .nbib Format: NLM
Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens.

International journal of general medicine

Omigie O, Okoror L, Umolu P, Ikuuh G.
PMID: 20360901
Int J Gen Med. 2009 Dec 29;2:171-5. doi: 10.2147/ijgm.s2641.

A four-year prospective study was carried out to determine the incidence and rate of development of resistance by common urinary tract infection (UTI) pathogens to quinolone antimicrobial agents. Results show that there is high intrinsic resistance to the quinolones...

Cite
Omigie O, Okoror L, Umolu P, et al. Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens. Int J Gen Med. 2009;2:171-5doi: 10.2147/ijgm.s2641.
Omigie, O., Okoror, L., Umolu, P., & Ikuuh, G. (2009). Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens. International journal of general medicine, 2171-5. https://doi.org/10.2147/ijgm.s2641
Omigie, Orhiosefe, et al. "Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens." International journal of general medicine vol. 2 (2009): 171-5. doi: https://doi.org/10.2147/ijgm.s2641
Omigie O, Okoror L, Umolu P, Ikuuh G. Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens. Int J Gen Med. 2009 Dec 29;2:171-5. doi: 10.2147/ijgm.s2641. PMID: 20360901; PMCID: PMC2840567.
Copy Download .nbib Format: NLM
Virulence Genes Content and Antimicrobial Resistance in Escherichia coli from Broiler Chickens.

Veterinary medicine international

Mohamed MA, Shehata MA, Rafeek E.
PMID: 25506467
Vet Med Int. 2014;2014:195189. doi: 10.1155/2014/195189. Epub 2014 Nov 24.

A total of 121 E. coli strains were isolated from broiler chickens (96 extraintestinal pathogenic (ExPEC) strains from diseased broiler chickens and 25 avian fecal E. coli (AFEC) from healthy ones). Ten of the isolates (6 from diseased chickens...

Cite
Mohamed MA, Shehata MA, Rafeek E. Virulence Genes Content and Antimicrobial Resistance in Escherichia coli from Broiler Chickens. Vet Med Int. 2014;2014:195189doi: 10.1155/2014/195189.
Mohamed, M. A., Shehata, M. A., & Rafeek, E. (2014). Virulence Genes Content and Antimicrobial Resistance in Escherichia coli from Broiler Chickens. Veterinary medicine international, 2014195189. https://doi.org/10.1155/2014/195189
Mohamed, Moemen A, et al. "Virulence Genes Content and Antimicrobial Resistance in Escherichia coli from Broiler Chickens." Veterinary medicine international vol. 2014 (2014): 195189. doi: https://doi.org/10.1155/2014/195189
Mohamed MA, Shehata MA, Rafeek E. Virulence Genes Content and Antimicrobial Resistance in Escherichia coli from Broiler Chickens. Vet Med Int. 2014;2014:195189. doi: 10.1155/2014/195189. Epub 2014 Nov 24. PMID: 25506467; PMCID: PMC4259055.
Copy Download .nbib Format: NLM
[Susceptibility of P. aeruginosa and enterobacteriaceae isolated from 1986 to 1994 in the Microbiology laboratory of the Infectious Diseases Institute of Perugia University].

Le infezioni in medicina

Pasticci MB, Baldelli F, Moretti A, Cardaccia A, Pauluzzi S.
PMID: 12847310
Infez Med. 1997 Mar;5(1):34-41.

From 1986 to 1994, 812 P. aeruginosa, 1997 E. coli, 437 P. mirabilis, 400 Klebsiella spp., 238 Enterobacter spp., 130 Serratia spp. strains were isolated from clinical materials in the Microbiology laboratory of the Infectious Diseases Institute of Policlinico...

Cite
Pasticci MB, Baldelli F, Moretti A, et al. Variazione della sensibilita agli antibiotici di Pseudomonas aeruginosa e di alcune specie di enterobatteri isolati nel laboratorio di Batteriologia dell'Istituto di Malattie Infettive dell'Università di Perugia dal 1986 al 1994. [Susceptibility of P. aeruginosa and enterobacteriaceae isolated from 1986 to 1994 in the Microbiology laboratory of the Infectious Diseases Institute of Perugia University]. Infez Med. 1997;5(1):34-41
Pasticci, M. B., Baldelli, F., Moretti, A., Cardaccia, A., & Pauluzzi, S. (1997). Variazione della sensibilita agli antibiotici di Pseudomonas aeruginosa e di alcune specie di enterobatteri isolati nel laboratorio di Batteriologia dell'Istituto di Malattie Infettive dell'Università di Perugia dal 1986 al 1994. [Susceptibility of P. aeruginosa and enterobacteriaceae isolated from 1986 to 1994 in the Microbiology laboratory of the Infectious Diseases Institute of Perugia University]. Le infezioni in medicina, 5(1), 34-41.
Pasticci, M B, et al. "Variazione della sensibilita agli antibiotici di Pseudomonas aeruginosa e di alcune specie di enterobatteri isolati nel laboratorio di Batteriologia dell'Istituto di Malattie Infettive dell'Università di Perugia dal 1986 al 1994." [Susceptibility of P. aeruginosa and enterobacteriaceae isolated from 1986 to 1994 in the Microbiology laboratory of the Infectious Diseases Institute of Perugia University]. Le infezioni in medicina vol. 5,1 (1997): 34-41.
Pasticci MB, Baldelli F, Moretti A, Cardaccia A, Pauluzzi S. Variazione della sensibilita agli antibiotici di Pseudomonas aeruginosa e di alcune specie di enterobatteri isolati nel laboratorio di Batteriologia dell'Istituto di Malattie Infettive dell'Università di Perugia dal 1986 al 1994. [Susceptibility of P. aeruginosa and enterobacteriaceae isolated from 1986 to 1994 in the Microbiology laboratory of the Infectious Diseases Institute of Perugia University]. Infez Med. 1997 Mar;5(1):34-41. Italian. PMID: 12847310.
Copy Download .nbib Format: NLM
The resistance of Pseudomonas aeruginosa strains to fluoroquinolone group of antibiotics.

Indian journal of medical microbiology

Algun U, Arisoy A, Gunduz T, Ozbakkaloglu B.
PMID: 17642707
Indian J Med Microbiol. 2004 Apr-Jun;22(2):112-4.

Fluoroquinolones are antibiotics that are very effective against many gram negative microorganisms, including P. aeruginosa. However, resistance to these antibiotics has been reported in recent years as well. In this study, the sensitivity of 136 P. aeruginosa strains, isolated...

Cite
Algun U, Arisoy A, Gunduz T, et al. The resistance of Pseudomonas aeruginosa strains to fluoroquinolone group of antibiotics. Indian J Med Microbiol. 2004;22(2):112-4
Algun, U., Arisoy, A., Gunduz, T., & Ozbakkaloglu, B. (2004). The resistance of Pseudomonas aeruginosa strains to fluoroquinolone group of antibiotics. Indian journal of medical microbiology, 22(2), 112-4.
Algun, U, et al. "The resistance of Pseudomonas aeruginosa strains to fluoroquinolone group of antibiotics." Indian journal of medical microbiology vol. 22,2 (2004): 112-4.
Algun U, Arisoy A, Gunduz T, Ozbakkaloglu B. The resistance of Pseudomonas aeruginosa strains to fluoroquinolone group of antibiotics. Indian J Med Microbiol. 2004 Apr-Jun;22(2):112-4. PMID: 17642707.
Copy Download .nbib Format: NLM
Atypical pneumonias: therapeutic possibilities.

International journal of antimicrobial agents

Akalin HE.
PMID: 18611582
Int J Antimicrob Agents. 1993 Nov;3:S75-9. doi: 10.1016/0924-8579(93)90038-7.

The atypical pneumonia syndrome is characterized by systemic complaints rather than respiratory symptoms. The causative pathogens include Mycoplasma, Chlamydia, Legionella and respiratory viruses (influenza, adenovirus, respiratory syncytial virus). The reported incidence of disease caused by these pathogens in community-acquired...

Cite
Akalin HE. Atypical pneumonias: therapeutic possibilities. Int J Antimicrob Agents. 1993;3:S75-9doi: 10.1016/0924-8579(93)90038-7.
Akalin, H. E. (1993). Atypical pneumonias: therapeutic possibilities. International journal of antimicrobial agents, 3S75-9. https://doi.org/10.1016/0924-8579(93)90038-7
Akalin, H E. "Atypical pneumonias: therapeutic possibilities." International journal of antimicrobial agents vol. 3 (1993): S75-9. doi: https://doi.org/10.1016/0924-8579(93)90038-7
Akalin HE. Atypical pneumonias: therapeutic possibilities. Int J Antimicrob Agents. 1993 Nov;3:S75-9. doi: 10.1016/0924-8579(93)90038-7. PMID: 18611582.
Copy Download .nbib Format: NLM
Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials.

International journal of antimicrobial agents

Naber KG, Baurecht W, Fischer M, Kresken M.
PMID: 18611611
Int J Antimicrob Agents. 1994 Aug;4(3):197-202. doi: 10.1016/0924-8579(94)90009-4.

The objective of the meta-analysis was to assess the efficacy and safety of a single oral dose of 800 mg pefloxacin in the treatment of acute uncomplicated lower urinary tract infections in women. A total of 1578 women were...

Cite
Naber KG, Baurecht W, Fischer M, et al. Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials. Int J Antimicrob Agents. 1994;4(3):197-202doi: 10.1016/0924-8579(94)90009-4.
Naber, K. G., Baurecht, W., Fischer, M., & Kresken, M. (1994). Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials. International journal of antimicrobial agents, 4(3), 197-202. https://doi.org/10.1016/0924-8579(94)90009-4
Naber, K G, et al. "Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials." International journal of antimicrobial agents vol. 4,3 (1994): 197-202. doi: https://doi.org/10.1016/0924-8579(94)90009-4
Naber KG, Baurecht W, Fischer M, Kresken M. Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials. Int J Antimicrob Agents. 1994 Aug;4(3):197-202. doi: 10.1016/0924-8579(94)90009-4. PMID: 18611611.
Copy Download .nbib Format: NLM
Chemotherapy trials in MB leprosy using conventional and newer drugs pefloxacin and minocycline.

Indian journal of dermatology, venereology and leprology

Katoch K, Katoch VM, Natrajan M, Sharma VD, Singh HB, Gupta UD.
PMID: 20877014
Indian J Dermatol Venereol Leprol. 2000 Jan-Feb;66(1):18-25.

One hundred, untreated, smear positive BB, BL and LL patients were treated with a regimen comprising of once a month, supervised, 600 mg of Rifampicin+ 400 mg Ofloxacin + 100 mg of Minocycline in addition to self administered 100...

Cite
Katoch K, Katoch VM, Natrajan M, et al. Chemotherapy trials in MB leprosy using conventional and newer drugs pefloxacin and minocycline. Indian J Dermatol Venereol Leprol. 2000;66(1):18-25
Katoch, K., Katoch, V. M., Natrajan, M., Sharma, V. D., Singh, H. B., & Gupta, U. D. (2000). Chemotherapy trials in MB leprosy using conventional and newer drugs pefloxacin and minocycline. Indian journal of dermatology, venereology and leprology, 66(1), 18-25.
Katoch, K, et al. "Chemotherapy trials in MB leprosy using conventional and newer drugs pefloxacin and minocycline." Indian journal of dermatology, venereology and leprology vol. 66,1 (2000): 18-25.
Katoch K, Katoch VM, Natrajan M, Sharma VD, Singh HB, Gupta UD. Chemotherapy trials in MB leprosy using conventional and newer drugs pefloxacin and minocycline. Indian J Dermatol Venereol Leprol. 2000 Jan-Feb;66(1):18-25. PMID: 20877014.
Copy Download .nbib Format: NLM
In vitro activity of eight fluoroquinolones against clinical isolates of Brucella melitensis.

Annals of Saudi medicine

Qadri SM, Akhter J, Ueno Y, Saldin H.
PMID: 17587989
Ann Saudi Med. 1993 Jan;13(1):37-40. doi: 10.5144/0256-4947.1993.37.

Since fluoroquinolones have generated much interest because of their excellent in vitro and in vivo activity, their pharmacokinetic propertiesm oral dosing and intracellular penetration, we tested the susceptibility of 146 recent clinical isolated of Brucella melitensis agaist eight 4-quinolone...

Cite
Qadri SM, Akhter J, Ueno Y, et al. In vitro activity of eight fluoroquinolones against clinical isolates of Brucella melitensis. Ann Saudi Med. 1993;13(1):37-40doi: 10.5144/0256-4947.1993.37.
Qadri, S. M., Akhter, J., Ueno, Y., & Saldin, H. (1993). In vitro activity of eight fluoroquinolones against clinical isolates of Brucella melitensis. Annals of Saudi medicine, 13(1), 37-40. https://doi.org/10.5144/0256-4947.1993.37
Qadri, S M, et al. "In vitro activity of eight fluoroquinolones against clinical isolates of Brucella melitensis." Annals of Saudi medicine vol. 13,1 (1993): 37-40. doi: https://doi.org/10.5144/0256-4947.1993.37
Qadri SM, Akhter J, Ueno Y, Saldin H. In vitro activity of eight fluoroquinolones against clinical isolates of Brucella melitensis. Ann Saudi Med. 1993 Jan;13(1):37-40. doi: 10.5144/0256-4947.1993.37. PMID: 17587989.
Copy Download .nbib Format: NLM
Antibrucella Activity of Quinolone Sparfloxacin.

Journal of travel medicine

Al-Ahdal MN, Cunha BA, Qadri SMH, Qadri SG, Ueno Y.
PMID: 9815397
J Travel Med. 1995 Dec 01;2(4):229-231. doi: 10.1111/j.1708-8305.1995.tb00665.x.

Background: Sparfloxacin is a new fluoroquinolone with excellent in vitro activity against a variety of Gram-positive and Gram-negative bacteria. Methods: In vitro antibacterial activity of this new drug was tested against 139 strains of Brucella melitensis. These strains were...

Cite
Al-Ahdal MN, Cunha BA, Qadri SMH, et al. Antibrucella Activity of Quinolone Sparfloxacin. J Travel Med. 1995;2(4):229-231doi: 10.1111/j.1708-8305.1995.tb00665.x.
Al-Ahdal, M. N., Cunha, B. A., Qadri, S. M. H., Qadri, S. G., & Ueno, Y. (1995). Antibrucella Activity of Quinolone Sparfloxacin. Journal of travel medicine, 2(4), 229-231. https://doi.org/10.1111/j.1708-8305.1995.tb00665.x
Al-Ahdal, et al. "Antibrucella Activity of Quinolone Sparfloxacin." Journal of travel medicine vol. 2,4 (1995): 229-231. doi: https://doi.org/10.1111/j.1708-8305.1995.tb00665.x
Al-Ahdal MN, Cunha BA, Qadri SMH, Qadri SG, Ueno Y. Antibrucella Activity of Quinolone Sparfloxacin. J Travel Med. 1995 Dec 01;2(4):229-231. doi: 10.1111/j.1708-8305.1995.tb00665.x. PMID: 9815397.
Copy Download .nbib Format: NLM
Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics.

Pharmaceutics

Bulitta JB, Jiao Y, Landersdorfer CB, Sutaria DS, Tao X, Shin E, Höhl R, Holzgrabe U, Stephan U, Sörgel F.
PMID: 31295857
Pharmaceutics. 2019 Jul 10;11(7). doi: 10.3390/pharmaceutics11070323.

Quinolone antibiotics present an attractive oral treatment option in patients with cystic fibrosis (CF). Prior studies have reported comparable clearances and volumes of distribution in patients with CF and healthy volunteers for primarily renally cleared quinolones. We aimed to...

Cite
Bulitta JB, Jiao Y, Landersdorfer CB, et al. Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics. Pharmaceutics. 2019;11(7)doi: 10.3390/pharmaceutics11070323.
Bulitta, J. B., Jiao, Y., Landersdorfer, C. B., Sutaria, D. S., Tao, X., Shin, E., Höhl, R., Holzgrabe, U., Stephan, U., & Sörgel, F. (2019). Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics. Pharmaceutics, 11(7), . https://doi.org/10.3390/pharmaceutics11070323
Bulitta, Jürgen B, et al. "Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics." Pharmaceutics vol. 11,7 (2019). doi: https://doi.org/10.3390/pharmaceutics11070323
Bulitta JB, Jiao Y, Landersdorfer CB, Sutaria DS, Tao X, Shin E, Höhl R, Holzgrabe U, Stephan U, Sörgel F. Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics. Pharmaceutics. 2019 Jul 10;11(7). doi: 10.3390/pharmaceutics11070323. PMID: 31295857; PMCID: PMC6681055.
Copy Download .nbib Format: NLM
Study on antibiotics, antibiotic resistance genes, bacterial community characteristics and their correlation in the landfill leachates.

Journal of applied microbiology

Bai L, Tan Z, Gong H, Xu M, Li Z, Yue J, Liu L, Yang D, Li R.
PMID: 34297455
J Appl Microbiol. 2022 Jan;132(1):445-458. doi: 10.1111/jam.15229. Epub 2021 Aug 10.

AIM: This study aimed to investigate the contamination levels of antibiotics and antibiotic resistance genes (ARGs) in the landfill leachates and their correlations with the bacteria.METHODS AND RESULTS: Using HPLC-MS, quantitative PCR and high-throughput sequencing, we measured the pollution...

Cite
Bai L, Tan Z, Gong H, et al. Study on antibiotics, antibiotic resistance genes, bacterial community characteristics and their correlation in the landfill leachates. J Appl Microbiol. 2021;132(1):445-458doi: 10.1111/jam.15229.
Bai, L., Tan, Z., Gong, H., Xu, M., Li, Z., Yue, J., Liu, L., Yang, D., & Li, R. (2022). Study on antibiotics, antibiotic resistance genes, bacterial community characteristics and their correlation in the landfill leachates. Journal of applied microbiology, 132(1), 445-458. https://doi.org/10.1111/jam.15229
Bai, Lirong, et al. "Study on antibiotics, antibiotic resistance genes, bacterial community characteristics and their correlation in the landfill leachates." Journal of applied microbiology vol. 132,1 (2022): 445-458. doi: https://doi.org/10.1111/jam.15229
Bai L, Tan Z, Gong H, Xu M, Li Z, Yue J, Liu L, Yang D, Li R. Study on antibiotics, antibiotic resistance genes, bacterial community characteristics and their correlation in the landfill leachates. J Appl Microbiol. 2022 Jan;132(1):445-458. doi: 10.1111/jam.15229. Epub 2021 Aug 10. PMID: 34297455.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 46 entries